ClinicalTrials.gg
CompletedNCT06635941Updated Nov 13, 2026

Predictive Model Identifies Painful Sedation-free Colonoscopy

An observational study in Pain, Non-sedated and Colonoscopy, sponsored by Ningbo No. 1 Hospital. Completed at 1 site in China. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-11-13.

Sponsored by Ningbo No. 1 Hospital · Observational

How we know

Updated Nov 13, 2026Primary completion movedStudy completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
1,003
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 247 studies in Pain with a site in China — 66 open to participants now, 72 under way, 2 of them phase 3. Pain · China.

Enrollment
8th of 34
1,003 · median 169
Started
2024
with 18 others
Observational
35 of 247
11 open now
Registered
171st of 247
by date

Among the 247 studies in Pain with a site in China, this one is the 8th largest by enrollment of the 34 observational ones that give a count, is one of 19 that started in 2024, is one of 35 observational ones, and was the 171st registered.

Pain

10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.

Browse Pain studies →

Open to participants now

66 of the 247 studies in Pain with a site in China are open now. Recruiting first, the newest first:

61 more — sign in →

All 66 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 247 studies in Pain with a site in China, or all of them as a file.
02

Study summary

Colorectal cancer is one of the most common cancers globally and a leading cause of cancer-related death. Colonoscopy is the standard screening method for colorectal cancer, significantly reducing mortality rates. However, the pain experienced during the procedure is one of the main reasons people avoid getting a colonoscopy. If operators can identify patients who are more likely to feel pain before the procedure, operators can take steps to reduce their discomfort. Previous research has developed a model to predict discomfort during colonoscopy, but this model have some limitations in clinical use. Therefore, investigators plan to develop a new model that also predicts the likelihood of painful colonoscopies.

This study aims to identify factors related to pain in non-sedated colonoscopy and create a more accurate prediction model to help reduce pain during the procedure.

A total of 1003 patients will be divided into two groups randomly for training and validation. Participants meet the inclusion criteria for this study, and investigators will ask participants to participate voluntarily. If participants agree, investigators will collect some of participants basic information and medical history, and assess participants' pain during the procedure.

Participants will only need to follow the doctors' instructions, complete bowel investigators' preparation, and undergo the colonoscopy as usual. The data collection will not interfere with participants' regular care

03

Conditions studied

  • Pain
  • Non-sedated
  • Colonoscopy

Browse trials for

04

Who can participate

The criteria were revised on the registry on Nov 13, 2026. See what changed

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

the people who is about to have a sedation-free colonoscopy

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patients undergoing non-sedated colonoscopy at Ningbo University Affiliated Hospital from September 2024 to October 2026.
  2. Age: Patients aged 18 to 75 years.
  3. Voluntary participation: Patients who voluntarily agree to participate in the study and have signed the form.

Exclusion criteria

Exclusion Criteria:

  1. Patients under 18 years old.
  2. Patients who are unwilling or unable to provide .
  3. Patients with malignant diseases, severe chronic heart or lung diseases, or those who have received treatment or radiation therapy for coronary artery or cerebrovascular events requiring hospitalization in the past 3 months.
  4. Patients with a history of colorectal resection or those with an incomplete colon.
  5. Patients who do not require reaching the ileocecal valve.
  6. Patients who have not completed bowel preparation or who have only used enemas for bowel cleaning.
  7. Patients with severe bowel obstruction or bowel perforation.
  8. Pregnant or breastfeeding women. -
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
1,003 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. colonoscopy-related pain

    The primary outcome is the the pain during the procedure of sedated-free colonoscopy according to a 4-point verbal rating scale (VRS-4), which is a four-category lanuage scale that classifies pain as no(0), slight(1), moderate(2), and se vere(3).

    Time frame: during the intubation procedure of sedated-free colonoscopy

07

Study locations

1 site
  • the First Affiliated Hospital of Ningbo University, Ningbo
    Ningbo, Zhejiang 315000, China
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2024 to primary completion in Oct 2026, 24 months.

Of 505 non-industry observational studies under Pain, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 42. This study's 24 months is above that.

Counting every sponsor, half of 520 studies reached it within 18 months; a quarter within 8 and three quarters within 41.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 13, 2026: primary completion Sep 2025 → Oct 2026 and completion Sep 2025 → Oct 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Sep 22, 2024
First posted
Oct 10, 2024
StartActual
Oct 10, 2024
Primary completionActual
Oct 16, 2026was Sep 2025
CompletionActual
Oct 16, 2026was Sep 2025
Last update
Nov 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Sep 21, 2025→Oct 16, 2026
Nov 13, 2026
Study completion
Sep 21, 2025→Oct 16, 2026
Nov 13, 2026
Enrollment
679→1003
Nov 13, 2026
Eligibility
1 inclusion criterion edited
What changed in the criteria
Inclusion criteria
  • EditedPatients undergoing non-sedated colonoscopy at Ningbo University Affiliated Hospital from September 2024 to September 2025October 2026.
Nov 13, 2026
Show all 1 update
  1. Nov 13, 2026
    Primary completion Sep 21, 2025→Oct 16, 2026
    Study completion Sep 21, 2025→Oct 16, 2026
    Enrollment 679→1003
    Eligibility 1 inclusion criterion edited
    What changed in the criteria
    Inclusion criteria
    • EditedPatients undergoing non-sedated colonoscopy at Ningbo University Affiliated Hospital from September 2024 to September 2025October 2026.
    + 3 other changes: identifiers, verification date and description

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT06635941
Lead sponsor
Ningbo No. 1 Hospital
Responsible party
Sponsor
First posted
Oct 10, 2024
Start date
Oct 10, 2024
Primary completion
Oct 16, 2026
Completion
Oct 16, 2026
Last update
Nov 13, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion